Publikationen, an denen er mitarbeitet Antonio I. Fernández-Giménez (15)

2023

  1. Towards a personalized health care using a divisive hierarchical clustering approach for comorbidity and the prediction of conditioned group risks

    Health Informatics Journal, Vol. 29, Núm. 4

2022

  1. IMPACT OF ATRIAL FIBRILLATION ON RENAL FUNCTION IN HEART FAILURE PATIENTS USING REAL WORLD DATA

    Journal of hypertension, Vol. 40, pp. e76

  2. Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4230-4239

  3. REAL WORLD IMPACT OF BLOOD PRESSURE CHANGES ON MORBIDITY AND MORTALITY IN TYPE 2 DIABETES

    Journal of hypertension, Vol. 40, pp. e186

  4. Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation

    Frontiers in Cardiovascular Medicine, Vol. 8

2020

  1. Acute kidney injury in heart failure: a population study

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 415-422

  2. Impact of acute hemoglobin falls in heart failure patients: A population study

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-9

  3. The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study

    Primary Care Diabetes, Vol. 14, Núm. 6, pp. 678-684

2018

  1. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: The ESCARVAL-risk study

    BMC Cardiovascular Disorders, Vol. 18, Núm. 1

2016

  1. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: The ESCARVAL-risk study

    Journal of Hypertension, Vol. 34, Núm. 6, pp. 1075-1083

  2. Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors froma registry-based cohort: The Estudio Cardiovascular Valencia-risk study

    Journal of Hypertension, Vol. 34, Núm. 11, pp. 2266-2273

2013

  1. Clinical inertia in poorly controlled elderly hypertensive patients: A cross-sectional study in spanish physicians to ascertain reasons for not intensifying treatment

    American Journal of Cardiovascular Drugs, Vol. 13, Núm. 3, pp. 213-219

2011

  1. Is there a predictive profile for clinical inertia in hypertensive patients?: An observational, cross-sectional, multicentre study

    Drugs and Aging, Vol. 28, Núm. 12, pp. 981-992

2010

  1. Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

    BMC Public Health, Vol. 10